Biosimilar and generic cancer drugs unlikely to bend cost...

Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA

Bennett, Charles L, Sartor, Oliver A, Armitage, James O, Kantarjian, Hagop
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(16)30653-2
Date:
January, 2017
File:
PDF, 107 KB
english, 2017
Conversion to is in progress
Conversion to is failed